Regulation of 11β-hydroxysteroid dehydrogenase type 2 by microRNA

Area of Science:

• Biochemistry
• Molecular Biology
• Physiology

Background:

• 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) enzyme activity is critical for aldosterone selectivity and blood pressure homeostasis.
• Diminished 11β-HSD2 activity is linked to salt-sensitive hypertension.
• The regulation of HSD11B2 gene expression, particularly in the kidney, is not fully understood.

Purpose of the Study:

• To investigate the role of microRNAs (miRNAs) in modulating 11β-HSD2 expression.
• To identify specific miRNAs that target the HSD11B2 gene.
• To explore miRNA involvement in HSD11B2 regulation in models of hypertension.

Main Methods:

• In silico analysis to predict miRNA binding sites on the HSD11B2 3'-untranslated region.
• Reporter assays to confirm 3'-untranslated region-dependent regulation of HSD11B2.
• miRNA profiling in kidney tissues and in vivo models with varying 11β-HSD2 activity.

Main Results:

• 53 and 27 miRNAs were predicted to bind to human and rat HSD11B2 3'-untranslated regions, respectively.
• Reporter assays confirmed HSD11B2 regulation by miRNAs.
• Differential expression of specific miRNAs (e.g., rno-miR-20a-5p, rno-miR-19b-3p) was observed in rat models with altered 11β-HSD2 activity and hypertension.

Conclusions:

• MicroRNA-dependent mechanisms play a significant role in regulating 11β-HSD2 levels.
• These regulatory pathways are implicated in both normal physiological states and disease conditions like salt-sensitive hypertension.
• The findings provide novel insights into the molecular basis of blood pressure control and kidney disease.